Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Antin

Showing results (31-40 of 119) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Investigation|February 1, 1985
Origin of cell populations after bone marrow transplantation. Analysis using DNA sequence polymorphismsD Ginsburg, J H Antin, B R Smith, et al.
The New England Journal of Medicine|January 13, 1994
Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemiaD L Porter, M S Roth, C McGarigle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimensA C Braverman, J H Antin, M T Plappert, et al.
Blood|April 1, 1997
Treatment of chronic graft-versus-host disease with clofazimineS J Lee, S A Wegner, C J McGarigle, et al.
Blood|April 1, 1994
Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairsA J Mitus, J H Antin, C J Rutherford, et al.
The American Journal of Drug and Alcohol Abuse|May 1, 1997
Substance abuse and bone marrow transplantG Chang, J H Antin, E J Orav, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2001
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow TransplantationJ H Antin, R Childs, A H Filipovich, et al.
Blood|December 3, 1998
The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemiaS J Lee, C Anasetti, K M Kuntz, et al.
Bone Marrow Transplantation|November 1, 1996
Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantationD L Porter, M S Roth, S J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2001
Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantationV T Ho, E Weller, S J Lee, et al.
Pageof 12

Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Investigation|February 1, 1985
Origin of cell populations after bone marrow transplantation. Analysis using DNA sequence polymorphismsD Ginsburg, J H Antin, B R Smith, et al.
The New England Journal of Medicine|January 13, 1994
Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemiaD L Porter, M S Roth, C McGarigle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimensA C Braverman, J H Antin, M T Plappert, et al.
Blood|April 1, 1997
Treatment of chronic graft-versus-host disease with clofazimineS J Lee, S A Wegner, C J McGarigle, et al.
Blood|April 1, 1994
Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairsA J Mitus, J H Antin, C J Rutherford, et al.
The American Journal of Drug and Alcohol Abuse|May 1, 1997
Substance abuse and bone marrow transplantG Chang, J H Antin, E J Orav, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2001
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow TransplantationJ H Antin, R Childs, A H Filipovich, et al.
Blood|December 3, 1998
The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemiaS J Lee, C Anasetti, K M Kuntz, et al.
Bone Marrow Transplantation|November 1, 1996
Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantationD L Porter, M S Roth, S J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2001
Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantationV T Ho, E Weller, S J Lee, et al.
Pageof 12